| STAA Stock | | | EUR 18.00 1.70 10.43% |
President
Dr. Keith Holliday, Ph.D. serves as Chief Technology Officer of the Company. Dr. Keith Holliday joined STAAR in August 2015 as Vice President of Research and Development. In March 2017, he assumed the role of the Chief Technology Officer. From 2007 to his arrival at STAAR, he served as Vice President, Research and Development at ReVision Optics where he oversaw the development of their corneal inlay technology that includes a hydrogel inlay for presbyopia correction, delivery devices and clinical methodologies as well as managing firstinman clinical studies. Previously, he was Director of Laser Technology at Advanced Medical Optics and Staff Laser Scientist at VISX. Prior to joining VISX, Dr. Holliday worked primarily in academia. He obtained his first degree in Physics and Electronics from the University of Saint Andrews in Scotland and a Ph.D. from the Laser Physics Centre at the Australian National University. He spent three years at the Swiss Federal Institute of Technology, where he was primarily involved with the utilization of optically active polymers and crystals, to develop materials and techniques for very high density, holographic optical storage and computational systems. Dr. Holliday holds patents in excimer laser beam detection, control and profiling, and methods to correct presbyopia that synergistically take into account the epitheliums response to corneal inlays, and he has also authored 37 peer reviewed publications in the scientific literature plus two book chapters and one singleauthored book. He is considered an expert on presbyopia and served as a committee member for the International Society of Presbyopia. since 2017.
| Age | 56 |
| Tenure | 8 years |
| Phone | 81 3 6866 2222 |
| Web | https://www.stanley.co.jp |
Holliday professional career includes his most recent position as Vice President, Research and Development at ReVision Optics where he oversaw the development of their corneal inlay technology that includes a hydrogel inlay for presbyopia correction, delivery devices and clinical methodologies as well as managing firstinman clinical studies. Previously, he was Director of Laser Technology at Advanced Medical Optics and Staff Laser Scientist at VISX. Prior to joining VISX, Dr. Holliday worked primarily in academia. He obtained his first degree in Physics and Electronics from the University of Saint Andrews in Scotland and a Ph.D. from the Laser Physics Centre at the Australian National University. He spent three years at the Swiss Federal Institute of Technology, where he was primarily involved with the utilization of optically active polymers and crystals, to develop materials and techniques for very high density, holographic optical storage and computational systems.
Stanley Electric Management Efficiency
The company has return on total asset
(ROA) of
0.0291 % which means that it generated a profit of $0.0291 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0575 %, meaning that it generated $0.0575 on every $100 dollars invested by stockholders. Stanley Electric's management efficiency ratios could be used to measure how well Stanley Electric manages its routine affairs as well as how well it operates its assets and liabilities.
Stanley Electric Co has accumulated 10
B in total debt with debt to equity ratio
(D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Stanley Electric has a current ratio of 3.2, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Stanley Electric until it has trouble settling it off, either with new capital or with free cash flow. So, Stanley Electric's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Stanley Electric sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Stanley to invest in growth at high rates of return. When we think about Stanley Electric's use of debt, we should always consider it together with cash and equity.
Stanley Electric Co., Ltd., together with its subsidiaries, manufacture, sells, and importexport of automotive and other light bulbs. Stanley Electric Co., Ltd. was founded in 1920 and is headquartered in Tokyo, Japan. STANLEY EL operates under Auto Parts classification in Germany and is traded on Frankfurt Stock Exchange. It employs 17121 people. Stanley Electric Co (STAA) is traded on Frankfurt Exchange in Germany and employs 17,022 people.
Management Performance
Stanley Electric Leadership Team
Elected by the shareholders, the Stanley Electric's board of directors comprises two types of representatives: Stanley Electric inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stanley. The board's role is to monitor Stanley Electric's management team and ensure that shareholders' interests are well served. Stanley Electric's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stanley Electric's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Toru Hashimoto, Ex Officer | |
| HansMartin Blickensdoerfer, Senior Vice President - Commercial Operations, Direct Markets Europe and China | |
| Gilbert Kliman, Director | |
| Elizabeth Yeu, Director | |
| Kazuki Takano, Chief Officer | |
| Louis Silverman, Independent Chairman of the Board | |
| Takaaki Kitano, Ex Officer | |
| Keisuke Ueda, MD, CFO | |
| James Francese, Senior Vice President - Commercial Operations, North American and APAC | |
| K Yu, Director | |
| Masahiro Sagae, Ex Officer | |
| Graydon Hansen, Chief Manufacturing Officer and Senior Vice President, Global Operations | |
| Stephen Farrell, Independent Director | |
| Satoshi Oki, Chief Officer | |
| Thomas Frinzi, Director | |
| Samuel Gesten, Vice President General Counsel, Corporate Compliance Officer and Secretary | |
| Deborah Andrews, Chief Accounting Officer, Vice President | |
| Caren Mason, President, Chief Executive Officer, Director | |
| Scott Barnes, Chief Medical Officer | |
| Toru Tanabe, Chief EVP | |
| Patrick Williams, Chief Financial Officer | |
| Toshie Endo, Ex Officer | |
| John Moore, Independent Director | |
| Jon Hayashida, Vice President of Global Clinical and Medical Affairs | |
| Keith Holliday, Vice President - Research & Development | |
| Yoshitsugu Matsushit, Ex Officer | |
| Yasuaki Kaizumi, Chief Pres | |
Stanley Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Stanley Electric a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Stanley Stock
Stanley Electric financial ratios help investors to determine whether Stanley Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stanley with respect to the benefits of owning Stanley Electric security.